4

Back to all posts

Press Release
AlphaLogix announces market release of AlphaFlo® canine allograft
AlphaFlo-Press-Release-Image

Equus Innovations, a manufacturer of advanced, next-generation veterinary regenerative products, in partnership with AlphaLogix, LLC (Argyle, Texas) announced today successful market release of a new canine allograft, AlphaFlo®.

Read the Press Release

You may want to read these articles

Comparing Equine Regenerative Therapy Options: PRP vs. RenoVō®

Comparing Equine Regenerative Therapy Options: PRP vs. RenoVō®

The key difference between PRP (Platelet-Rich Plasma) and RenoVō® lies in consistency, composition, and practical application. While PRP relies on platelets collected and processed on-site, RenoVō® is a ready-to-use, acellular equine amniotic tissue allograft prepared...

Alternative to PRP for Equines: Why Consider RenoVō®

Alternative to PRP for Equines: Why Consider RenoVō®

Why RenoVō®? Alternative to PRP Platelet-Rich Plasma (PRP) has been widely used in equine regenerative care, but it isn’t without its challenges. PRP preparations can vary significantly depending on blood quality, processing techniques, and the presence of white blood...

RenoVō® CASE STUDY: Ocular Squamous Cell Carcinoma

RenoVō® CASE STUDY: Ocular Squamous Cell Carcinoma

Case presentation: September 8, 2020: A 10-Year-Old Gelding presented to Milestone Veterinary Care, Backus, MN, with a conjunctival squamous cell carcinoma at the lateral canthus causing visual impairment and destruction of the eye. The attending veterinarian, Fonda...